Trial Profile

A Phase II clinical trial of suprachoroidal(SC) delivery for AU-011

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 17 Jun 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Jun 2020 Accordoing to an Aura Biosciences media release, the company expects to initiate this study during the third quarter of 2020.
22 Oct 2019 New trial record
15 Oct 2019 Accordoing to an Aura Biosciences media release, recently executed a licensing agreement with Clearside Biomedical for use of Clearsides suprachoroidal space (SCS) Microinjector for the treatment of intraocular cancers.This trial is expected to initiate during the first half of 2020.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com